Article
Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia
24 Mar 2020
Abstract excerpt
One of the key features of acute myeloid leukemia (AML), a group of very aggressive myeloid malignancies, is their strikingly heterogenous outcomes. Accurate biomarkers are needed to improve prognostic assessment. Glutamate oxaloacetate transaminase 1 (GOT1) is essential for cell proliferation and apoptosis by regulating cell’s metabolic dependency on glucose. It is unclear whether the expression level of GOT1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
